Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics
Jingda Cai(Central South University), Renrong Wu(Central South University), Dongyu Kang(Central South University), Yidong Shen(Nantong University), Chuhan Song(Central South University), Furu Liu(Central South University), Mengxi Sun(Huazhong Agricultural University), Xingjie Peng(Central South University), Qiongqiong Wu(Central South University), Yu‐Han Su(Central South University), Menghui Gao(Central South University), Tiannan Shao(Second Affiliated Hospital of Zhejiang University), Ye Yang(Seoul National University), Yujun Long(Second Xiangya Hospital of Central South University), Li Li(Central South University), Xiaoyi Wang(Hubei University of Medicine), Peng Xie(Central South University), Jing Huang(Central South University), Jingmei Xiao(Central South University), Weiyan Wang(Central South University), Ping Shao(Tianjin Children's Hospital), Yuyan Huang(Army Medical University), Jianjun Ou(Central South University)
Cited by 5
Related Papers
Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic
|Translational Psychiatry|2020|312
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
|Nature Communications|2020|219
Stress Impairs Reconsolidation of Drug Memory via Glucocorticoid Receptors in the Basolateral Amygdala
|Journal of Neuroscience|2008|142
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
|Diabetes & Metabolism Journal|2023|123